New blood test uses cell-free DNA shed from placenta to accurately predict preeclampsia
A new blood test has an 80% accuracy in predicting preterm preeclampsia, according to a study published today, Feb. 12, in ...
Mercy offering new cancer screening that can detect hard-to-screen cancers even earlier
Mercy is offering a new, revolutionary cancer screening that can detect around fifty types of cancer even earlier with a ...
These Desi Spices Can Reduce Your Cancer Risk
Fennel seeds contain anethole, a compound that has been found to exhibit anti-cancer properties by inhibiting cancer cell ...
Revolutionary Biology Discovery Combines DNA and RNA To Fight Cancer
A study reveals DNA and RNA epigenetics work together as a complementary system for precise gene regulation, crucial for cell ...
How DNA's environment shapes smoking-related cancer risk
Cigarette smoke causes cancer primarily by damaging the DNA. A new study that mapped these damages has revealed that the way ...
Too Old to Operate3d
Pilot study: Urine cell-free DNA with low-pass whole genome sequencing can detect and molecularly type upper tract urothelial carcinomas.
Upper tract urothelial carcinoma (UTUC) is an aggressive disease that is challenging to biopsy and diagnose, frequently yielding nondiagnostic cytology and tissue specimens. Therefore, UTUC is often ...
The American Journal of Managed Care13d
Small Cell Lung Cancer
Investigators wanted to analyze the diagnostic performance of methylation-sensitive restriction enzyme digestion followed by sequencing using cell-free DNA and explore the cancer signal origin of ...
The American Journal of Managed Care6d
Refining Remission Assessment in Aggressive B-Cell Lymphomas
Despite research showing the benefits of circulating tumor DNA as an indicator of disease remission in B-cell lymphoma, ...
NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today commented on recent updates by the NCCN on circulating tumor DNA (ctDNA) molecular residual disease (MRD) ...